Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05649670 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Acute Stroke: Prehospital Versus In-HospitAL Initiation of Recanalization Therapy- ASPHALT

Study acronym: ASPHALT
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary completion date: Jan 2, 2026 to Oct 16, 2026
    • Start date changed from estimate of Jan 2, 2023 to Oct 16, 2023
    • Study sites: 10 to 11
    • Study completion date: Sep 1, 2026 to Jun 16, 2027
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
ASPHALT is an academic-driven open-label randomized controlled trial of Mobile Stroke Unit (MSU) deployment versus standard care in France, with blinded assessment of efficacy endpoints. 450 patients with confirmed acute ischemic stroke will be recruited over a 3-year period, with 3-month follow-up.
Trial Details
NCT Number NCT05649670
Lead Sponsor Centre Hospitalier St Anne
Collaborators: Assistance Publique - Hôpitaux de Paris, Ministry of Health, France
Conditions
(from sponsor)		 Stroke, Acute
Related terms Stroke
Enrollment 450 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov